All terms in GO

Label Id Description
gene expression involved in extracellular matrix organization GO_1901148
Any gene expression that is involved in extracellular matrix organization. Gene expression includes both transcription to produce an RNA transcript, and the translation of that mRNA into protein. Protein maturation is included in gene expression when required to form an active form of a product from an inactive precursor form.
salicylic acid binding GO_1901149
Binding to salicylic acid.
intermediate mesodermal cell fate commitment GO_0048393
The process in which the developmental fate of a cell becomes restricted such that it will develop into an intermediate mesoderm cell.
intermediate mesodermal cell fate determination GO_0048394
The process in which a cell becomes capable of differentiating autonomously into a intermediate mesoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.
intermediate mesoderm formation GO_0048391
The process that gives rise to the intermediate mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
intermediate mesodermal cell differentiation GO_0048392
The process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell.
positive regulation of intermediate mesodermal cell fate determination GO_0048397
Any process that activates or increases the frequency, rate or extent of intermediate mesoderm cell fate determination.
regulation of intermediate mesodermal cell fate determination GO_0048395
Any process that modulates the frequency, rate or extent of intermediate mesoderm cell fate determination.
vistamycin metabolic process GO_1901150
The chemical reactions and pathways involving vistamycin.
intermediate mesodermal cell fate specification GO_0048398
The process in which a cell becomes capable of differentiating autonomously into an intermediate mesoderm cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed.
vistamycin catabolic process GO_1901151
The chemical reactions and pathways resulting in the breakdown of vistamycin.
vistamycin biosynthetic process GO_1901152
The chemical reactions and pathways resulting in the formation of vistamycin.
negative regulation of intermediate mesodermal cell fate determination GO_0048396
Any process that stops, prevents, or reduces the frequency, rate or extent of intermediate mesoderm cell fate determination.
paromomycin metabolic process GO_1901153
The chemical reactions and pathways involving paromomycin.
paromomycin catabolic process GO_1901154
The chemical reactions and pathways resulting in the breakdown of paromomycin.
aminoglycoside antibiotic catabolic process GO_0030649
The chemical reactions and pathways resulting in the breakdown of an aminoglycoside antibiotic, any member of a group of broad spectrum antibiotics, of similar toxicity and pharmacology, that contain an aminodeoxysugar, an amino- or guanidino-substituted inositol ring, and one or more residues of other sugars. The group includes streptomycin, neomycin, framycetin, kanamycin, paromomycin, and gentamicin.
paromomycin biosynthetic process GO_1901155
The chemical reactions and pathways resulting in the formation of paromomycin.
neomycin metabolic process GO_1901156
The chemical reactions and pathways involving neomycin.
neomycin catabolic process GO_1901157
The chemical reactions and pathways resulting in the breakdown of neomycin.
neomycin biosynthetic process GO_1901158
The chemical reactions and pathways resulting in the formation of neomycin.